4R-Tau seeding activity unravels molecular subtypes in patients with Progressive Supranuclear Palsy

4R-Tau seeding activity unravels molecular subtypes in patients with Progressive Supranuclear Palsy

Here’s our simpler summary:

Researchers studied a condition called Progressive Supranuclear Palsy (PSP), which involves abnormal tau protein in the brain. They wanted to understand why some patients with PSP progress faster than others. To do this, they looked at the tau protein in 20 different areas of the brain in 25 PSP patients.

They discovered that a specific kind of tau, called HMW-Tau, was linked to the speed of disease progression. More of this HMW-Tau in the primary motor cortex (an area of the brain) was linked to faster disease progression. They also found out that the immune system played a role in the differences seen between patients.

They further studied where and how this HMW-Tau was present in the brain and noticed it varied between patients and even within different parts of the brain. In some patients, the presence of this HMW-Tau was linked to tau "clumps" or oligomers.

In short, the type and location of tau protein in the brain could be a reason why PSP progresses differently in patients.

Full Original Article-
doi: https://doi.org/10.1101/2023.09.28.559953
By: Ivan Martinez-Valbuena, Seojin Lee, Enrique Santamaria, Joaquin Fernandez Irigoyen, Shelley Forrest, Jun Li, Hidetomo Tanaka, Blas Couto, Nikolai Gil Reyes, Hania Qamar, Ali M Karakani, Ain Kim, Konstantin Senkevich, Ekaterina Rogaeva, Susan H Fox, Carmela Tartaglia, Naomi P Visanji, Tallulah Andrews, Anthony E Lang, Gabor Geza Kovacs

 

Back to blog

Leave a public comment:

Please note, comments need to be approved before they are published.

  • 🥯 Bagel Fundraiser

    🥯 Bagel Fundraiser

    JOIN THE COLEEN CUNNINGHAM FOUNDATION 🥯 Bagel Fundraiser FOR THE BENEFIT OF THOSE WITHAtypical Parkinson Diseases NOVEMBER 2ND • 11-1 PM AT THE ROCKVILLE JCC IN PARTNERSHIP WITH BETHESDA BAGELS

    🥯 Bagel Fundraiser

    JOIN THE COLEEN CUNNINGHAM FOUNDATION 🥯 Bagel Fundraiser FOR THE BENEFIT OF THOSE WITHAtypical Parkinson Diseases NOVEMBER 2ND • 11-1 PM AT THE ROCKVILLE JCC IN PARTNERSHIP WITH BETHESDA BAGELS

  • HOPE by Bhavna

    HOPE by Bhavna

    Remember the first timerobins sang in your garden,their delicate bodies pulsing with song,their hearts daring to rise, like yours.How the moon spilled its silver over your window,and your mother said,...

    HOPE by Bhavna

    Remember the first timerobins sang in your garden,their delicate bodies pulsing with song,their hearts daring to rise, like yours.How the moon spilled its silver over your window,and your mother said,...

  • Active Neurodegenerative Disease Clinical Trials (PSP, MSA, DLB, CBS, Parkinsonian Syndromes)

    Active Neurodegenerative Disease Clinical Trial...

    Progressive Supranuclear Palsy (PSP) Trials ClinicalTrials.gov ID: NCT06355531 – PROSPERPurpose: To evaluate whether FNP-223 slows disease progression in PSP, using the PSP Rating Scale (PSPRS) over 52 weeks. The trial also...

    1 comment

    Active Neurodegenerative Disease Clinical Trial...

    Progressive Supranuclear Palsy (PSP) Trials ClinicalTrials.gov ID: NCT06355531 – PROSPERPurpose: To evaluate whether FNP-223 slows disease progression in PSP, using the PSP Rating Scale (PSPRS) over 52 weeks. The trial also...

    1 comment
  • Recruiting participants for a groundbreaking study: “Assessing Cognitive Trajectories in Progressive Supranuclear Palsy Using Remote Computerized Reaction Time Tasks.”

    Recruiting participants for a groundbreaking st...

    Melbourne, Victoria – September 9, 2025 – The CCF Coleen Cunningham Foundation is partnering with researchers at the Alfred Hospital and Monash University to recruit participants for a groundbreaking study:...

    Recruiting participants for a groundbreaking st...

    Melbourne, Victoria – September 9, 2025 – The CCF Coleen Cunningham Foundation is partnering with researchers at the Alfred Hospital and Monash University to recruit participants for a groundbreaking study:...

1 of 4